DMN Breakdown Meets Neuroplasticity: Convergent Pathways in Psychedelic, Ketamine, and Bedtime Oral Glutamatergic Approaches to Depression

Read full text Summarise with VIRAT
Authors: Ngo Cheung
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Major depressive disorder remains one of the leading causes of disability, and many patients do not respond adequately to conventional monoaminergic antidepressants. Recent work has drawn attention to the default mode network (DMN) as an important neural substrate of rumination and negative self-referential thinking. This short report argues that the rapid antidepressant effects seen across several mechanistically different interventions may converge on a shared process: temporary decoupling of the DMN together with enhanced synaptogenesis.Serotonergic psychedelics appear to induce a robust, high-entropy form of DMN desynchronization through 5-HT2A-mediated glutamate release, while also driving spine formation through BDNF-TrkB-mTOR signaling. Ketamine and some oral ketamine-mimetic approaches seem to produce a more moderate form of DMN dissociation through glutamate surge and mTOR-dependent plasticity. A newer low-cost strategy, the Cheung Glutamatergic Regimen, which combines dextromethorphan plus CYP2D6 inhibition, piracetam, and optional glutamine, has been proposed as a way of engaging related glutamatergic mechanisms when given at bedtime. The rationale for bedtime dosing is that it may align with the natural DMN decoupling that occurs during deep N3 slow-wave sleep, and pregabalin augmentation has been proposed as a way to deepen and prolong this plasticity-favorable window.This model may be especially relevant in tightly regulated settings where classic psychedelics are not available. Although the framework is supported by neuroimaging, preclinical findings, and early case material, direct testing will require controlled trials and combined polysomnography-functional imaging studies.

Fields of Study & Subjects

Treatment of Major Depression Psychedelics and Drug Studies Transcranial Magnetic Stimulation Studies

Publication details

Journal / source
Figshare
Publication date
1 January 2026
Language
EN
Document type
Preprint